Linear epitopes on the capsid protein of norovirus commonly elicit high antibody response among past-infected individuals

Virology Journal

Research

Aixia Zhai¹  Fang Zhang¹  Yilin Deng¹  Taojun He¹  Yanping Zhang¹  Hui Wu¹  Chao Wu¹  Bin Li¹  Jie Ning¹  Hanmei Yuan¹ 

[1] Department of Laboratory Medicine, The Eighth Affiliated Hospital of Sun Yat-sen University, 518033, Shenzhen, Guangdong, China;

关键词: Epitopes;    IgG;    Norovirus;    VP1;    VP2;   

DOI  :  10.1186/s12985-023-02087-y

 received in 2023-02-25, accepted in 2023-06-01,  发布年份 2023

来源: Springer

【 摘 要 】

BackgroundHuman norovirus (HuNoV) is the leading cause of acute nonbacterial gastroenteritis globally, and its infection is usually self-limited, so most people become past Norovirus (NoV)-infected individuals. It is known that some antibody responses may play a critical role in preventing viral infection and alleviating disease; however, the characteristics and functions of particular antibody responses in persons with previous infections are not fully understood. Capsid proteins, including VP1 and VP2, are crucial antigenic components of NoV and may regulate antibody immune responses, while epitope-specific antibody responses to capsid proteins have not been comprehensively characterized.MethodsWe prepared purified VP1 and VP2 proteins by ion exchange chromatography and measured serum antigen-specific IgG levels in 398 individuals by ELISA. Overlapping 18-mer peptides covering the full length of VP1 and VP2 were synthesized, and then we identified linear antigenic epitopes from 20 subjects with strong IgG positivity. Subsequently, specific antibody responses to these epitopes were validated in 185 past infected individuals, and the conservation of epitopes was analyzed. Finally, we obtained epitope-specific antiserum by immunizing mice and expressed virus-like particles (VLPs) in an insect expression system for a blockade antibody assay to evaluate the receptor-blocking ability of epitope-specific antibodies.ResultsThe IgG responses of VP1 were significantly stronger than those of VP2, both of which had high positive rates of over 80%. The overall positive rate of VP1-IgG and/or VP2-IgG was approximately 94%, which may be past NoV-infected individuals. Four linear antigenic B-cell epitopes of capsid proteins were identified, namely, VP1199–216, VP1469–492, VP297–120, and VP2241–264, all of which were conserved. The IgG response rates of the above epitopes in past NoV-infected individuals were 38.92%, 22.16%, 8.11% and 28.11%, respectively. In addition, VP1199–216- and VP1469–492-specific antibodies can partially block the binding of VLPs to the receptor histo-blood group antigen (HBGA).ConclusionThis is the first study to describe specific antibody responses of VP2 and to identify its B-cell epitopes. Our findings offer data for a more thorough understanding of norovirus capsid protein-specific IgG responses and could provide useful information for designing and developing vaccines.

【 授权许可】

CC BY   
© The Author(s) 2023

【 图 表 】

Fig. 4

40517_2023_259_Article_IEq46.gif

40517_2023_259_Article_IEq41.gif

Fig. 1

Fig. 2

40517_2023_259_Article_IEq31.gif